Clinical Trial Policy meeting
This article was originally published in The Gray Sheet
Executive Summary
Medicare Coverage Advisory Committee (MCAC) will address CMS' reconsideration of the Clinical Trial Policy at a public meeting Dec. 13 in Baltimore. The policy, implemented in 2000, provides coverage of routine costs for Medicare beneficiaries enrolled in "qualified" clinical studies. CMS opened a national coverage decision in July to revise the policy in light of "changes to the clinical research landscape" (1"The Gray Sheet" Aug. 21, 2006, p. 9). A proposed decision is now expected by April 10, with a final decision due in July...
You may also be interested in...
CMS Should Clarify Coverage For Device Trials, Manufacturers Say
Device manufacturers are asking for a clearer path to Medicare coverage of their clinical studies
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.